ACHN apparently received an independent review from Dr. Jules Dienstag on Monday (3/8/10) who called ACH-1625 the "best and most pristine looking of the proteases in development today." The nature or context of this review was not disclosed.
Who is Jules Dienstag?
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”